Michael Aronstein Net Worth & Insider Trades
Michael Aronstein - Director, Angiogenex, Inc
What is Michael Aronstein's Net Worth?
The current estimated net worth of Angiogenex, Inc's Director, Michael Aronstein, is estimated to be about $700 . Michael Aronstein owns about 5,500,000 units of Angiogenex, Inc common stock. Recently at Angiogenex, Inc, Michael Aronstein has sold an estimated value of $0 worth.
What is Michael Aronstein's Past Insider Trading?
Michael Aronstein's largest purchase order was 1,000,000 units , worth over $200K on February 4, 2019. In total, Michael Aronstein has made about 1 transaction recently at Angiogenex, Inc. Michael Aronstein usually trades in February, with the busiest year in 2019.
MICHAEL ARONSTEIN
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Michael Aronstein's Salary in 2018?
As Director of Angiogenex, Inc, Michael Aronstein has a total base salary of $0 . The vast majority of their compensation came in the form of stock awards of $0 , option awards of $0 , and other earnings, plans or compensations of $0 .
What is Michael Aronstein's' Mailing Address?
- Mailing address is 3 Purchase Lane Rye NY 10580 NY
Angiogenex, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|
| Robert Benezra, PRES, CEO, CSO | 2018 | $0 | $0 | $0 | $0 | $0 |
| Michael Strage, VP, COO | 2018 | $0 | $0 | $0 | $0 | $0 |
| Martin Murray, CFO | 2018 | $0 | $0 | $0 | $0 | $0 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000046/aggxsch14a_040119apg.htm
What are Angiogenex, Inc's Past Insider Trades?
Angiogenex, Inc's most recent insider trade came on February 4, 2019 by Michael Aronstein who bought 1,000,000 units worth $200K . In the years Angiogenex, Inc was active, insiders at Angiogenex, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in February, with the busiest year in 2019. The most active traders at the company are and Michael Aronstein, Director .
AngioGenex, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||